Advanced Registry Search Results
Search Criteria
- Lobbyist name (consultant or in-house lobbyist): FINDLAY, MARK OR;
- Senior Officer name: FINDLAY, MARK
Refine By
Document Type
Registrations Status
Activity Type
Subject Matter of the Lobbying Activity
Ministries/Provincial Entities
If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search
Advanced Registry Search Results
Results: 1-8 of 8
-
AstraZeneca Canada Inc.
Activity type: Organization
Senior Officer: Jane Chung
Registration: 19 of 32 (2020-02-27 to2020-05-04 )
Posted: 2020-02-27Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
AstraZeneca Canada Inc.
Activity type: Organization
Senior Officer: Jane Chung
Registration: 18 of 32 (2019-08-20 to2020-02-20 )
Posted: 2019-08-20Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
AstraZeneca Canada Inc.
Activity type: Organization
Senior Officer: Ed Dybka
Registration: 13 of 32 (2017-01-17 to2017-07-16 )
Posted: 2017-01-17Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
AstraZeneca Canada Inc.
Activity type: Organization
Senior Officer: Ed Dybka
Registration: 12 of 32 (2016-07-20 to2017-01-16 )
Posted: 2016-07-25Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
AstraZeneca Canada Inc.
Activity type: Organization
Senior Officer: Elaine Campbell
Registration: 6 of 32 (2013-05-02 to2013-11-28 )
Posted: 2013-05-02Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
AstraZeneca Canada Inc.
Activity type: Organization
Senior Officer: Elaine Campbell
Registration: 5 of 32 (2012-09-14 to2013-04-17 )
Posted: 2012-10-03Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
AstraZeneca Canada Inc.
Activity type: Organization
Senior Officer: Elaine Campbell
Registration: 4 of 32 (2012-02-02 to2012-09-06 )
Posted: 2012-02-06Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
AstraZeneca Canada Inc.
Activity type: Organization
Senior Officer: Marion McCourt
Registration: 3 of 32 (2011-06-29 to2012-02-01 )
Posted: 2011-07-04Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
- Date Modified: